{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:02:36Z","timestamp":1789549356266,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10067-026-08365-8","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T03:56:08Z","timestamp":1786938968000},"page":"6171-6179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of hematological inflammatory indices with disease activity and interstitial lung disease in systemic sclerosis"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4871-6035","authenticated-orcid":false,"given":"Irem","family":"\u015eahino\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6266-2454","authenticated-orcid":false,"given":"Sadettin","family":"Uslu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"8365_CR1","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D (2017) Systemic sclerosis. Lancet (London, England) 390:1685\u20131699. https:\/\/doi.org\/10.1016\/S0140-6736(17)30933-9","journal-title":"Lancet (London, England)"},{"key":"8365_CR2","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","volume":"4","author":"DP Tashkin","year":"2016","unstructured":"Tashkin DP, Roth MD, Clements PJ et al (2016) Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med 4:708\u2013719. https:\/\/doi.org\/10.1016\/S2213-2600(16)30152-7","journal-title":"Lancet Respir Med"},{"key":"8365_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9113388","author":"A Utsunomiya","year":"2020","unstructured":"Utsunomiya A, Oyama N, Hasegawa M (2020) Potential biomarkers in systemic sclerosis: a literature review and update. J Clin Med. https:\/\/doi.org\/10.3390\/jcm9113388","journal-title":"J Clin Med"},{"key":"8365_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/annrheumdis-2016-209768","volume":"76","author":"G Valentini","year":"2017","unstructured":"Valentini G, Iudici M, Walker UA et al (2017) The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index. Ann Rheum Dis 76:270\u2013276. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209768","journal-title":"Ann Rheum Dis"},{"key":"8365_CR5","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/apm.12722","volume":"125","author":"Z Yang","year":"2017","unstructured":"Yang Z, Zhang Z, Lin F et al (2017) Comparisons of neutrophil-, monocyte-, eosinophil-, and basophil-lymphocyte ratios among various systemic autoimmune rheumatic diseases. APMIS 125:863\u2013871. https:\/\/doi.org\/10.1111\/apm.12722","journal-title":"APMIS"},{"key":"8365_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10067-019-04685-0","volume":"39","author":"ME Yayla","year":"2020","unstructured":"Yayla ME, \u0130lgen U, Okatan \u0130E et al (2020) Association of simple hematological parameters with disease manifestations, activity, and severity in patients with systemic sclerosis. Clin Rheumatol 39:77\u201383. https:\/\/doi.org\/10.1007\/s10067-019-04685-0","journal-title":"Clin Rheumatol"},{"key":"8365_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13037","volume":"49","author":"GL Erre","year":"2019","unstructured":"Erre GL, Paliogiannis P, Castagna F et al (2019) Meta-analysis of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in rheumatoid arthritis. Eur J Clin Invest 49:e13037. https:\/\/doi.org\/10.1111\/eci.13037","journal-title":"Eur J Clin Invest"},{"key":"8365_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12071702","author":"B-W Song","year":"2022","unstructured":"Song B-W, Kim A-R, Kim Y-K et al (2022) Diagnostic value of neutrophil-to-lymphocyte, platelet-to-lymphocyte, and monocyte-to-lymphocyte ratios for the assessment of rheumatoid arthritis in patients with undifferentiated inflammatory arthritis. Diagnostics (Basel). https:\/\/doi.org\/10.3390\/diagnostics12071702","journal-title":"Diagnostics (Basel)"},{"key":"8365_CR9","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2020\/e1450","volume":"75","author":"L Wang","year":"2020","unstructured":"Wang L, Wang C, Jia X et al (2020) Relationship between neutrophil-to-lymphocyte ratio and systemic lupus erythematosus: a meta-analysis. Clinics (Sao Paulo) 75:e1450. https:\/\/doi.org\/10.6061\/clinics\/2020\/e1450","journal-title":"Clinics (Sao Paulo)"},{"key":"8365_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12112633","author":"A Zinellu","year":"2022","unstructured":"Zinellu A, Mangoni AA (2022) Platelet and red blood cell volume indices in patients with rheumatoid arthritis: a systematic review and meta-analysis. Diagnostics (Basel). https:\/\/doi.org\/10.3390\/diagnostics12112633","journal-title":"Diagnostics (Basel)"},{"key":"8365_CR11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/labmed\/lmaa002","volume":"51","author":"A Peirovy","year":"2020","unstructured":"Peirovy A, Malek Mahdavi A, Khabbazi A et al (2020) Clinical usefulness of hematologic indices as predictive parameters for systemic lupus erythematosus. Lab Med 51:519\u2013528. https:\/\/doi.org\/10.1093\/labmed\/lmaa002","journal-title":"Lab Med"},{"key":"8365_CR12","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.3906\/sag-1601-87","volume":"46","author":"N Atilla","year":"2016","unstructured":"Atilla N, Y\u0131ld\u0131r\u0131m \u00c7etin G, Balkarl\u0131 A (2016) Association of neutrophil\/lymphocyte ratio with the degree ofinterstitial lung disease in systemic sclerosis. Turk J Med Sci 46:1871\u20131874. https:\/\/doi.org\/10.3906\/sag-1601-87","journal-title":"Turk J Med Sci"},{"key":"8365_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073636","author":"A Buonacera","year":"2022","unstructured":"Buonacera A, Stancanelli B, Colaci M, Malatino L (2022) Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23073636","journal-title":"Int J Mol Sci"},{"key":"8365_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1621209","volume":"16","author":"Y Wu","year":"2025","unstructured":"Wu Y, Huang Y, Wu Y et al (2025) Systemic immune-inflammation index as a versatile biomarker in autoimmune disorders: insights from rheumatoid arthritis, lupus, and spondyloarthritis. Front Immunol 16:1621209. https:\/\/doi.org\/10.3389\/fimmu.2025.1621209","journal-title":"Front Immunol"},{"key":"8365_CR15","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum 65:2737\u20132747. https:\/\/doi.org\/10.1002\/art.38098","journal-title":"Arthritis Rheum"},{"key":"8365_CR16","first-page":"1281","volume":"22","author":"P Clements","year":"1995","unstructured":"Clements P, Lachenbruch P, Siebold J et al (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22:1281\u20131285","journal-title":"J Rheumatol"},{"key":"8365_CR17","doi-asserted-by":"publisher","first-page":"421","DOI":"10.12865\/CHSJ.50.03.09","volume":"50","author":"C Palici","year":"2024","unstructured":"Palici C, Dinescu SC, Bita CE et al (2024) Assessment of neutrophil-lymphocyte ratio and systemic immune-inflammation index in systemic scleroderma patients with focus on cardiopulmonary manifestations. Curr Health Sci J 50:421\u2013427. https:\/\/doi.org\/10.12865\/CHSJ.50.03.09","journal-title":"Curr Health Sci J"},{"key":"8365_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5152\/eurasianjmed.2025.251103","volume":"57","author":"V Ecesoy","year":"2025","unstructured":"Ecesoy V, Ecesoy H (2025) Assessment of new inflammatory indexes in systemic sclerosis with interstitial lung disease. Eurasian J Med 57:1\u20137. https:\/\/doi.org\/10.5152\/eurasianjmed.2025.251103","journal-title":"Eurasian J Med"},{"key":"8365_CR19","first-page":"101","volume":"29","author":"D Tezcan","year":"2020","unstructured":"Tezcan D, Turan \u00c7, Y\u0131lmaz S et al (2020) What do simple hematological parameters tell us in patients with systemic sclerosis? Acta Dermatovenerol Alp Pannonica Adriat 29:101\u2013107","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"8365_CR20","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00296-020-04604-6","volume":"40","author":"A Kim","year":"2020","unstructured":"Kim A, Kim Y, Kim G-T et al (2020) Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as potential makers for digital ulcers and interstitial lung disease in patients with systemic sclerosis: cross-sectional analysis of data from a prospective cohort study. Rheumatol Int 40:1071\u20131079. https:\/\/doi.org\/10.1007\/s00296-020-04604-6","journal-title":"Rheumatol Int"},{"key":"8365_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101122","volume":"25","author":"L Doridot","year":"2019","unstructured":"Doridot L, Jeljeli M, Ch\u00eane C, Batteux F (2019) Implication of oxidative stress in the pathogenesis of systemic sclerosis via inflammation, autoimmunity and fibrosis. Redox Biol 25:101122. https:\/\/doi.org\/10.1016\/j.redox.2019.101122","journal-title":"Redox Biol"},{"key":"8365_CR22","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/cei.13238","volume":"195","author":"M Brown","year":"2019","unstructured":"Brown M, O\u2019Reilly S (2019) The immunopathogenesis of fibrosis in systemic sclerosis. Clin Exp Immunol 195:310\u2013321. https:\/\/doi.org\/10.1111\/cei.13238","journal-title":"Clin Exp Immunol"},{"key":"8365_CR23","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s10067-025-07913-y","volume":"45","author":"C-W Liu","year":"2026","unstructured":"Liu C-W, Chang Y-A, Yu C-L et al (2026) Interstitial lung disease in systemic sclerosis-a retrospective cross-sectional study in Taiwan. Clin Rheumatol 45:1011\u20131022. https:\/\/doi.org\/10.1007\/s10067-025-07913-y","journal-title":"Clin Rheumatol"},{"key":"8365_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1061738","volume":"9","author":"H Li","year":"2022","unstructured":"Li H, Zhang X, Yu L et al (2022) Comparing clinical characteristics of systemic sclerosis with or without interstitial lung disease: a cross-sectional study from a single center of the Chinese Rheumatism Data Center. Front Med 9:1061738. https:\/\/doi.org\/10.3389\/fmed.2022.1061738","journal-title":"Front Med"},{"key":"8365_CR25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/annrheumdis-2020-217455","volume":"80","author":"A-M Hoffmann-Vold","year":"2021","unstructured":"Hoffmann-Vold A-M, Allanore Y, Alves M et al (2021) Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database. Ann Rheum Dis 80:219\u2013227. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217455","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08365-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08365-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08365-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:04:43Z","timestamp":1789545883000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08365-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["8365"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08365-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"9 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study was approved by Celal Bayar University School of Medicine Local Ethic Committee (Date: October 20, 2024 Decision No: 20.478.486\/2705). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Raw data can be shared if requested.","order":3,"name":"Ethics","label":"Open data sharing note","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}